At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BIOR Biora Therapeutics, Inc.
Pre-Market Trading 11-22 06:18:18 EST
1.63
+0.01
+0.62%
High1.67
Low1.55
Vol53.02K
Open1.60
D1 Closing1.62
Amplitude7.41%
Mkt Cap7.07M
Tradable Cap5.22M
Total Shares4.34M
T/O85.23K
T/O Rate1.66%
Tradable Shares3.20M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Biora Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and Systemic oral delivery platform for oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.